Skip main navigation

You do not have any saved searches

  • The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro

  • Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I

  • Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages

  • Effects of Extended-Release Nicotinic Acid on Apolipoprotein (a) Kinetics in Hypertriglyceridemic Patients

  • Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia—Brief Report

  • Stable Isotope Kinetic Study of ApoM (Apolipoprotein M)

  • Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab

  • VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly

  • Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town

  • Leu22_Leu23 Duplication at the Signal Peptide of PCSK9 Promotes Intracellular Degradation of LDLr and Autosomal Dominant Hypercholesterolemia

  • Abstract 19556: Hypercholesterolemia in a Pcsk5 Mouse Mutant Show P5 Proteolytic Degradation of P9 is Essential for Normal Regulation of Serum Cholesterol

  • Abstract 14235: Plasma PCSK9 Levels and Clinical Outcomes in the Treating to New Targets Trial: A Nested Case-Control Study

  • Abstract 14536: Low PCSK-9 Serum Levels Do Not Predict Insulin Resistance in a Racially Admixed Population. The ELSA-Brasil

  • Abstract 10006: Expression and Function of Pcsk9 in Human Pancreatic Beta Cells

  • Abstract 10009: Circulating Pcsk9 Levels Are Not Associated With the Conversion to Type 2 Diabetes

  • Abstract 9665: Reduced Lipoprotein(a) Associated With the Apolipoprotein E2 Genotype Confers Cardiovascular Protection in Familial Hypercholesterolemia

  • Abstract 9909: A Detrimental Genetic Environment Resulting in Extreme Lipoprotein (a) Levels and Premature C H D in a French Family

  • Abstract 9986: Lipoprotein (a) Cellular Uptake ex-vivo and Hepatic Capture in-vivo is Insensitive to Pcsk9 Inhibition With Alirocumab

  • Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk